IP and Gender Conference at AU

Rebecca Tushnet does such a remarkable job of blogging summaries of conference presentations that I almost feel as if I attended the event. Here are links to her summaries of the presentations and comments at the recent IP/ Gender: The Unmapped Connections, held at the American University Washington College of Law:

Dan Burk’s presentation

Carys Craig’s presentation

Comments on Burk and Craig

Eileen Kane’s presentation

Ann Bartow’s presentation

Rebecca Tushnet’s presentation

Comments on Kane and Bartow and Tushnet

There were additional presentations scheduled; I’ll update this post if Rebecca posts more summaries. As always, hers is service to the IP community that is above and beyond any call of duty.

UPDATE:

Susan Scafidi’s presentation

Vicki Phillips’s presentation

Boatema Boateng’s presentation

4 thoughts on “IP and Gender Conference at AU

  1. IP & Gender, IP & Social Justice….is there anything that doesn’t go with IP? Somebody ought to patent it. Or copyright it, I guess. No, it’s kind of a business model, these conferences. I claim the sports conferences (e.g. “IP & Hockey,” “Basketball & IP”) and all the desserts (“IP & Key Lime Pie” etc). I know I should be going broad but I think sports and desserts are where the money is and I want to save money on filing.

  2. That gender and social justice issues related to intellectual property issues are marginalized and subordinated isn’t actually all that amusing to some of us. Kudos to law schools and law profs who support fresh approaches to legal analysis – it’s important work.

  3. I’m sorry my whimsy was taken for ill will. I’ll try to keep my dry wit or lack thereof in better check. Just to notice that there are fashions in scholarship though is not to say that what is fashionable is not worthwhile. That’s not where I was coming from, anyway. To my mind, there are few things more worthy of investigating than changing the IP rules for drugs to make them more available in the developing world, for example.

  4. (I mentioned developing-world drug licensing because it is an “IP & Social Justice” issue, according to the conception of a recent conference)

Comments are closed.